Effects of cisatracurium in children during halothane-nitrous oxide anesthesia

Journal of Clinical Anesthesia

Volumn 10, Issue 3, 1998, Pages 195-199

  Brandom, Barbara W ^a,b   Woelfel, Susan K ^a   Ference, Andrea ^b   Dayal, Bimal ^b   Cook, D Ryan ^a   Kerls, Susan ^c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Anesthesia: halothane, nitrous oxide; Nondepolarizing neuromuscular blocking agents: cisatracurium; Patient: children

Indexed keywords

CISATRACURIUM; EDROPHONIUM; HALOTHANE; NITROUS OXIDE;

ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; EVOKED MUSCLE RESPONSE; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; MALE; NEUROMUSCULAR BLOCKING; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL;

ANESTHESIA RECOVERY PERIOD; ANESTHESIA, INHALATION; ANESTHETICS, INHALATION; ANTIDOTES; ATRACURIUM; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; EDROPHONIUM; ELECTROMYOGRAPHY; FEMALE; FORECASTING; HALOTHANE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MUSCLE CONTRACTION; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NITROUS OXIDE; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS;

EID: 0032080625     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(98)00007-5     Document Type: Article

References (14)

1. Wastila WB, Maehr RB, Turner GL, Hill DA, Savarese JJ: Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology 1996;85:169-77.
2. 2-opioid anesthesia. Anesth Analg 1996;83:823-9.
3. Belmont MR, Lien CA, Quessy S, et al: The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82: 1139-45.
4. Lien CA, Belmont MR, Abalos A, et al: The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1995;82:1131-8.
5. Kisor DF, Schmith VD, Wargin WA, Lien CA, Ornstein E, Cook DR: Importance of the organ-independent elimination of cisatracurium. Anesth Analg 1996;83:1065-71.
6. Meretoja OA, Taivainen T, Wirtavuori K: Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Br J Anaesth 1995;74:6-11.
7. Meretoja OA, Wirtavuori K, Taivainen T, Olkkola KT: Time course of potentiation of mivacurium by halothane and isoflurane in children. Br J Anaesth 1996;76:235-8.
8. Brandom BW, Rudd GD, Cook DR: Clinical pharmacology of atracurium in paediatric patients. Br J Anaesth 1983;55-Suppl 1:117S-121S.
9. Kopman AF: Pancuronium, gallamine, and d-tubocurarine compared: is speed of onset inversely related to drug potency? Anesthesiology 1989;70:915-20.
10. Mellinghoff H, Radbruch L, Diefenbach C, Buzello W: A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Anesth Analg 1996;83:1072-5.
11. Kalli I, Meretoja OA: Infusion of atracurium in neonates, infants and children. A study of dose requirements. Br J Anaesth 1988; 60:651-4.
12. Brandom BW, Cook DR, Woelfel SK, Rudd GD, Fehr B, Lineberry CG: Atracurium infusion requirements in children during halothane, isoflurane, and narcotic anesthesia. Anesth Analg 1985;64:471-6.
13. Brandom BW, Westman HR: Effects of 0.86 mg/kg cisatracurium in an infant [Letter]. Anesthesiology 1996;85:688-9.
14. Meretoja OA, Taivainen T, Wirtavuori K: Cisatracurium during halothane and balanced anaesthesia in children. Paediatr Anaesth 1996;6:373-8.